BIOADAPTIVES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BIOADAPTIVES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.3K | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $12.7K | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $28.6K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $17.2K | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $19.8K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $16.3K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $9.9K | Mar 30, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.5K | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $4.0K | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $10.8K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $7.1K | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $10.1K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.1K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.9K | Mar 30, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.56M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($899.2K) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($712.5K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($895.6K) | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | ($1.05M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($847.2K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($238.9K) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($1.41M) | May 12, 2020 |
| FY2015 | Dec 31, 2015 | ($227.4K) | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | ($2.58M) | Apr 14, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.04M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($602.1K) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($228.9K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($421.9K) | Apr 10, 2024 |
| FY2015 | Dec 31, 2015 | ($227.3K) | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | ($2.44M) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($18.8K) | Apr 15, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($516.0K) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($249.5K) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($223.8K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($227.3K) | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | ($158.7K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($106.9K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($168.1K) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($420.1K) | May 12, 2020 |
| FY2015 | Dec 31, 2015 | ($72) | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | ($58.6K) | Apr 14, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.0K | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Apr 14, 2026 |
| FY2014 | Dec 31, 2014 | ($1.6K) | Apr 15, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $225.9K | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $261.9K | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $104.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $37.3K | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $148.6K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $18.8K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $24.2K | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $110.1K | May 12, 2020 |
| FY2015 | Dec 31, 2015 | $7.2K | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | $70.8K | Apr 14, 2016 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.36M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $1.73M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $1.75M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.49M | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $1.24M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.40M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $864.1K | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | $803.8K | May 12, 2020 |
| FY2015 | Dec 31, 2015 | $210.6K | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | $70.9K | Apr 14, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.13M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($1.46M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2023 | ($1.65M) | Apr 14, 2026 |
| FY2024 | Dec 31, 2022 | ($1.45M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | ($1.09M) | Apr 10, 2024 |
| FY2022 | Dec 31, 2020 | ($1.38M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | ($839.9K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | ($693.7K) | Mar 30, 2021 |
| FY2019 | Dec 31, 2017 | ($3.5K) | May 12, 2020 |
| FY2015 | Dec 31, 2015 | ($203.4K) | Apr 14, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.72M) | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | ($9.16M) | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | ($8.26M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($7.55M) | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | ($6.66M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($5.61M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($4.76M) | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | ($4.52M) | May 12, 2020 |
| FY2015 | Dec 31, 2015 | ($2.82M) | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | ($2.59M) | Apr 14, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.2K | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | $261.9K | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | $88.6K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $82.9K | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | $82.9K | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | $4.6K | Mar 30, 2021 |
| FY2020 | Dec 31, 2019 | $12.3K | Mar 30, 2021 |
| FY2020 | Dec 31, 2018 | $56.2K | Mar 30, 2021 |
| FY2015 | Dec 31, 2015 | $99 | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | $37.9K | Apr 14, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2014 | Dec 31, 2014 | 0 | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | 0 | Apr 15, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 14, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.01M | Apr 14, 2026 |
| FY2025 | Dec 31, 2024 | 8.22M | Apr 14, 2026 |
| FY2024 | Dec 31, 2023 | 5.97M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 252.55M | Apr 10, 2024 |
| FY2022 | Dec 31, 2021 | 50.82M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 20.83M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 18.58M | Mar 30, 2021 |
| FY2019 | Dec 31, 2018 | 18.10M | May 12, 2020 |
| FY2015 | Dec 31, 2015 | 12.74M | Apr 14, 2016 |
| FY2015 | Dec 31, 2014 | 12.64M | Apr 14, 2016 |